✦ LIBER ✦

Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability

✍ Scribed by Si H. Yang; Myung G. Lee

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 148 KB
Volume: 29
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.628

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic and intestinal first-pass effect

Hepatic and intestinal first-pass effects of oltipraz in rats

✍ Soo K. Bae; Jin W. Kim; Young H. Kim; Yoon G. Kim; Sang G. Kim; Myung G. Lee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

It was reported that the mean value of the extent of absolute oral bioavailability (F) of oltipraz at a dose of 20 mg/kg was 41.2% and only 2.68% of the oral dose was unabsorbed from the gastrointestinal tract in rats. Hence, the low F in rats could be due to considerable first-pass (gastric, intest

Pharmacokinetics and hepatic first-pass

Pharmacokinetics and hepatic first-pass effect of (−)-carbovir in the anesthetized rat

✍ Inmaculada Soria; Dr. Cheryl L. Zimmerman 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 2 views

Studies were designed to allow an in vivo estimation of the hepatic extraction ratio and to test the hypothesis that the pharmacokinetic parameters of (-)-CBV are significantly different during anesthesia. (-)-CBV was administered as an IV bolus followed by IV infusion into either the portal (n = 3)

Dose-dependent pharmacokinetics and firs

Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats

✍ Young H. Choi; Young S. Lee; Soo H. Bae; Tae K. Kim; Bong-Y. Lee; Myung G. Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

## Abstract The pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous (5, 10, 20 and 50 mg/kg) and oral (10, 20 and 50 mg/kg) administration of mirodenafil, and the first‐pass effect of mirodenafil after intravenous, oral, intraportal, intragastric and intrad

Pharmacokinetics of L-FMAUS, a new antiv

Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability

✍ Hye J. Chung; Joo H. Lee; Sung J. Woo; Hee K. Park; Chang H. Koo; Myung G. Lee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract The pharmacokinetics of L‐FMAUS after intravenous and oral administration (20, 50 and 100 mg/kg) to rats, gastrointestinal first‐pass effect of L‐FMAUS (50 mg/kg) in rats, __in vitro__ stability of L‐FMAUS, blood partition of L‐FMAUS between plasma and blood cells of rat blood, and prot

Dose-dependent pharmacokinetics of a new

Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect

✍ Eun J. Kim; Sun-O. Kim; Dong H. Lee; Hong Lim; Myung G. Lee 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Pharmacokinetics of a new reversible pro

Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats

✍ Kye S. Han; Yoon G. Kim; Joong K. Yoo; Jong W. Lee; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G